JP Morgan Private Wealth Advisors’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-25,925
Closed -$153K 1943
2022
Q2
$153K Hold
25,925
﹤0.01% 1849
2022
Q1
$501K Buy
+25,925
New +$595K ﹤0.01% 1534
2021
Q4
Sell
-22,919
Closed -$940K 2013
2021
Q3
$940K Sell
22,919
-6,881
-23% -$250K ﹤0.01% 1244
2021
Q2
$1.07M Buy
+29,800
New +$1.1M ﹤0.01% 1161

Other funds holding GDRX

JP Morgan Private Wealth Advisors's GDRX Position: Q3 2022 in Review

JP Morgan Private Wealth Advisors sold out of GoodRx Holdings (GDRX) in Q3 2022, closing a stake of 25,925 shares — an estimated $153K sold.

JP Morgan Private Wealth Advisors first reported a position in GDRX in Q2 2021 and held it in 4 quarters. The position peaked at $1.07M in Q2 2021. 180 funds tracked by Wall St. Rank hold GDRX as of Q3 2022.

  • JP Morgan Private Wealth Advisors reported no remaining GoodRx Holdings position as of Q3 2022 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 25,925 GoodRx Holdings shares in Q3 2022, an estimated $153K.
  • JP Morgan Private Wealth Advisors first reported a position in GoodRx Holdings in Q2 2021 and held it in 4 quarters.
  • JP Morgan Private Wealth Advisors's GoodRx Holdings position peaked at $1.07M in Q2 2021.
  • 180 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2022.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2022, filed 4 Nov 2022.